sodium nitroprusside in 0.9% sodium chloride

Slate Run Pharmaceuticals, LLC🇺🇸 United States

FDA Page

Effective Date: Nov 15, 2023
Approval ID: 6f02e4ac-5f7c-4003-b9b7-283f489cddb0
Products: 3 registered
Version: 2

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use SODIUM NITROPRUSSIDE in 0.9% SODIUM CHLORIDE INJECTION safely and effectively. See full prescribing information for SODIUM NITROPRUSSIDE in 0.9% SODIUM CHLORIDE INJECTION. SODIUM NITROPRUSSIDE in SODIUM CHLORIDE injection, for intravenous use Initial U.S. Approval: 1988

Quick Stats

Total Products3

Labelers2

Label Sections18

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.